Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) FCF Margin (2019 - 2023)

Benitec Biopharma (BNTC) has disclosed FCF Margin for 5 consecutive years, with 58514.29% as the latest value for Q2 2023.

  • Quarterly FCF Margin changed N/A to 58514.29% in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 288514.29% through Mar 2024, down 26088782.0% year-over-year, with the annual reading at 24017.33% for FY2023, 221870.0% down from the prior year.
  • FCF Margin hit 58514.29% in Q2 2023 for Benitec Biopharma, down from 7438.89% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 9022.86% in Q2 2020 to a low of 350000.0% in Q4 2020.
  • Historically, FCF Margin has averaged 71674.39% across 5 years, with a median of 7438.89% in 2023.
  • Biggest five-year swings in FCF Margin: plummeted -34600519bps in 2020 and later soared 33671200bps in 2021.
  • Year by year, FCF Margin stood at 3994.81% in 2019, then tumbled by -8661bps to 350000.0% in 2020, then soared by 96bps to 13288.0% in 2021, then crashed by -215bps to 41821.43% in 2022, then plummeted by -40bps to 58514.29% in 2023.
  • Business Quant data shows FCF Margin for BNTC at 58514.29% in Q2 2023, 7438.89% in Q1 2023, and 41821.43% in Q4 2022.